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Background
Gastrointestinal stromal tumors are mesenchymal neo-
plasms of the gastrointestinal tract, arising from the mus-
cular layer. Revent immunohistochemical studies have
shown that up to 94% of GISTs express 117, and 60–70%
of GISTs stain for CD 34. GISTs account for 1% of all
malignant tumors of gastrointestinal tract; they arise from
stomach in the 40–60% of cases whereas they account
only for 3% of gastric malignant neoplasms. GISTs can
occur at any age but onset most commonly in the sixth
and the seventh decades of life.
Methods
We report the case of a 69-year-old male patient admitted
to our surgical department with weakness, progressive
abdominal straining and weight loss of 5 kg in 6 months.
Physical examination showed a voluminous mass palpa-
ble in the upper- to mid abdomen. The computed tomog-
raphy (CT) revealed an enormous solid lesion,
heterogeneous, polilobate, hypervascular, arising from
peritoneal sheet and mesentery, dislocating small bowel
and causing hydronephrosis I grade (see Figure 1).
Surgery was performed in October 2008. At laparotomy
appeared an enormous solid mass, hypervascular, origi-
nating from the anterior wall of the stomach of 15 × 20 cm
of diameter. The neoplasm was completely isolated and a
partial gastrectomy Billroth 2 was performed along with a
partial resection of omentum and the radical excision of
the tumor (see Figure 2). The mass weighed 7 kg. The post-
operative course was uneventful and the patient was dis-
charged ten days after surgery.
Results
The final histological findings confirmed the diagnosis of
malignant neoplasm pT2 with fused cells compatible with
fibrosarcoma poorly differentiated. The immunohisto-
chemistry of the fused cell showed no positivity for CD
34, actin, ema andcytokeratins. The proliferative index
was 7 mitoses per 10 HPF.
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As reported in literature the GIST described in our case
presented aspecific clinical finding and a not clear origin
at CT scanning. In our case the high mitotic index (>5
mitoses per 10 HPF) and the tumor size greater than 5 cm
manifest an aggressive biological behavior associated with
a poor prognosis. In this case anyway the tumor doesn't
result positive to CD 117 or CD 34 though presenting
fused cells with mesenchimal phenotype.
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